Publications by authors named "C Flohr"
Children with severe atopic dermatitis (AD), refractory to conventional systemic treatment as well as single-agent biologic and Janus kinase inhibitor (JAKi) such as abrocitinib, currently face a lack of treatment options. In response to this clinical conundrum, we present three cases of severe and refractory pediatric AD successfully managed with combined dupilumab and abrocitinib. These children had exhausted all conventional treatments and had undergone treatment with both dupilumab and abrocitinib individually, as well as dupilumab in conjunction with methotrexate.
View Article and Find Full Text PDFArticle Synopsis
- A recent cross-sectional study conducted by dermatologists from Denmark, the UK, and Switzerland in May 2022 assessed the prevalence of skin diseases among adults in Tasiilaq, East Greenland, revealing significant health concerns.* -
- Out of 295 participants (about 22.5% of the adult population), 69% exhibited visible signs of skin disease, with common conditions being hand eczema, lichen simplex, and scabies being the most prevalent.* -
- The findings highlight a high prevalence of skin diseases and emphasize the need for improved access to dermatological care in the region, as many cases were severe and differed from typical presentations.*